The joint dialogue event is co-hosted by Novartis Access and the Novartis Foundation, with experts from Novartis (No. 2 on the DiversityInc Top 50 Companies list), academia and nonprofit organizations speaking and attending.
It will be an opportunity to look back on the lessons learned during the first year of Novartis Access, an innovative social business approach to treat chronic diseases in lower-income countries. Speakers from both Novartis and its partners will present findings and discuss how they addressed challenges in the implementation, one year into the program.
This dialogue will also provide a broader view on how Novartis is working with other organizations to explore innovative approaches to address chronic diseases in lower income countries by both strengthening healthcare systems and improving access to medicines.
Speakers and panelists will include representatives from the World Health Organization, PATH, Red Cross, Pink Ribbon Red Ribbon, the London School of Hygiene & Tropical Medicine and Boston University, as well as government delegates.
Joerg Reinhardt, Novartis Chairman, will also deliver a keynote address.
Improving care for chronic patients in lower-income countries: the patient journey
Friday, November 29, 2016
09:30 15:30 CET
Basel, Novartis Campus, Gehry auditorium
This event will be available to watch via a live webcast on November 29.
Series of dialogue events on access
This event will document the progress and results of Novartis Access one year after launch, in terms of country implementation, impact evaluation, and partnerships. It is part of a dialogue series with key stakeholders.